with previously published data' suggesting that mutation of the antithrombin III structural gene is the cause of inherited antithrombin III deficiency in some families.
Antithrombin III (AT III) is the main physiological inhibitor of thrombin, factor Xa, and other serine proteases generated during coagulation.3 Familial deficiency of AT III results in marked predisposition to venous thromboembolic disease in adult life. The deficiency is inherited as an autosomal dominant trait and occurs with an estimated incidence of 1 in 2000 of the general population.4 Of those affected, 40 to 70% become symptomatic with recurrent and sometimes fatal peripheral venous thrombosis and pulmonary embolism at some time during their lives.4 Since the disorder was first described in 1965,5 over 100 families have been described.6 In most patients with this disorder about half the normal levels of AT III Genotypes for the PstI the two genetic markers in this analysis. From this and other autoradiographs we were unable to detect any gross rearrangement of AT III gene structure that could not be accounted for by normal variation.
The relationship between these markers and the AT III deficiency trait in kindred a is shown in fig 2. Major deletion of the AT III gene of one chromosome could be discounted in seven affected members of kindred a because they were heterozygous (-/+) for at least one of the two markers. Of the remaining five apparently homozygous affected members (-/-or +/+), who could conceivably be hemizygous at this locus, two (III.16 and IV.6) had affected parents who were heterozygous for these markers. One of these markers must have been passed on to the affected child, and therefore subjects III.16 and IV.6 must be truly homozygous. Similarly, any major deletion in kindred b could be discounted in two affected members who were heterozygous for the PstI marker and in one apparently homozygous patient (11.2) who had an affected parent with heterozygosity for the PstI marker (fig 3) .
The information from the two two-allele polymorphisms can be combined to generate four possible haplotypes (--, -+, +-, ++ 
